O Controle da Dor em Pacientes Portadores de Câncer Avançado: um Problema Nacional Negligenciado
DOI:
https://doi.org/10.32635/2176-9745.RBC.1984v30n3.3461Keywords:
Cancer Pain/prevention & control, Neoplasms/drug therapy, Hydromorphone, MethadoneAbstract
Many advanced cancer patients suffer from chronic and severe pain, even after the use of the modem tools of chemotherapy, radiotherapy and neurosurgery for pain control, and they need narcotic analgesics in adequate doses and at regular intervals for a dignified life relatively pain free. The fear of patients becoming dependent on narcotics is unfounded in the contexto of terminal illnes. In general, physicians have an inadequate knowledge ou pain control. In our Country, there only are two types of narcotics (morphine and meperidine) and only as injectables. The atitude of our governamental authorities has been exclusively as of police. The problem of the Street addict interferes with the one suffering from advanced cancer, what is not fair. The sale and distribuition of narcotics are complex and difficult. We must have oral narcotics in the market, for example Methadone, hydromorphone tablets (Dilaudid) and liquid oral solution of morphine or hydromorphone. We also need suppositories of morphine and more potent injectables. In thepast years, several narcotics were withdrawn from the market, most likely due to the illegal abuse, leaving the pain patient without adequate relief. Unfortunately, a large number of patients spends their last days in excrutiating pain in our Country. It is a social, moral and ethical obligation of the medical profession and government to ease this problem.
Downloads
References
CATALOANO RB. The medical approach to management of pain caused by cancer. Seminars in Oncology 1975; 2: 379.
PAPPER S. The undesirable patient. J. Chronic Dis. 1970; 22: 777-9. DOI: https://doi.org/10.1016/0021-9681(70)90079-2
FGILMA AG, GOODMAN LS, GILMAN A, EDS. GOODMAN & GILMAN'S The Pharmacological Basis of Therapeutics. 6th ed. New York: MacMillan Publishing Co. Inc; 1980: 494.
HEALTH AND PUBLIC POLICY COMMITTEE. American College of Physicians. Ann Int. Med. 1980; 99: 870-3.
MARKS RM, SACHAR EJ. Under treatment of medical inpacients with narcotic analgesics. Ann Int Med 1973; 78: 173-81. DOI: https://doi.org/10.7326/0003-4819-78-2-173
CHARAP AD. The knowledge, attitudes and experience of medical personnel treating pain in the terminalill. Mount Sinai J Med. (NY) 1978; 45-561-80.
LACK SA. MANAGEMENT OF PAIN (ABSTRACT). in Abstracts of the Ninth Annual Medical Symposium on Success in Cancer Management Today. Boston, Massachussets Division of the American Câncer Society and the Greater Boston Medical Society; 1977.
KANNER RB, FOLEY KM. Use and abuse of narcotic analgesics in a cancer pain clinic (Abastract). Proc. Am. Assoe. Cancer Res. 1980; 21: 381.
PORTER J, JICK H. Addiction rare in patients treated with narcoties. N. EngI J Med 1980; 302: 123. DOI: https://doi.org/10.1056/NEJM198001103020221
BEAVER WT. Management of cancer pain with parenteral medication. JAMA 1980; 244: 2653-7. DOI: https://doi.org/10.1001/jama.244.23.2653
TWYCROSS Rg. Diseases of central nervous System: relief of terminal pain. Brit Med J. 1975; 4: 212-4. DOI: https://doi.org/10.1136/bmj.4.5990.212
ANGELL M. The Quaiitu of Mercy. New EngI J Med 1982; 306: 98-9. DOI: https://doi.org/10.1056/NEJM198201143060210
MOERTEL CG, AHMANN DL, TAYLOR WF. A comparative evaluation of marketed drugs. N EngI J Med 1972; 286-813-5. DOI: https://doi.org/10.1056/NEJM197204132861504
REULER JB, GERARD DE, NARDONE DA. The chronic pain syndrome: misconceptions and management. Ann Int Med 1980; 93: 588-96. DOI: https://doi.org/10.7326/0003-4819-93-4-588
SHIRMM DS, LOGUE GL, MALTBIE AA, DUGAN S. Medical management of chronic pain. JAMA 1979; 241-2408-12. DOI: https://doi.org/10.1001/jama.1979.03290480042022
TWYCROSS R. Value of cocaine in opiate-containing elixirs. Br Med J 1977;2: 1348. DOI: https://doi.org/10.1136/bmj.2.6098.1348
TWYCROSS RG. Choice of Strong analgesics in terminal cancer: diamorphine or morphine. Pain 1977; 3: 93-104. DOI: https://doi.org/10.1016/0304-3959(77)90072-0
MOUNT BM, AJEMIAN I. SCOTT JF. Use of lhe Brompton mixture in treating the chronic pain of malignant disease. Can Med Assoc J 1976; 115: 1124.
MELJACK R, MPUNT BM, GORDON JM. The Brompton mixture versus morphine solution given oraiiy: effects on pain. Can Med Assoc J 1979; 120: 435-8.
PORTNOW JM, CORBETT RJ. Oral Methadone for relief of chronic pain from cancer (letter). New EngI J Med 1982; 306: 989. DOI: https://doi.org/10.1056/NEJM198204223061612
HOUDE RW. The rational use of narcotic anaigesics for controlling cancer pain. Drug Ther 1980; 10: 638.
FOOD AND DRUG ADMINISTRATION. New dosage form of Dilaudid. FDA Drug Bulletin 1983; 13: 23.
